✦ LIBER ✦

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

✍ Scribed by Punit D. Wadhwa; Pingfu Fu; Omer N. Koc; Brenda W. Cooper; Robert M. Fox; Richard J. Creger; David L. Bajor; Teja Bedi; Mary J. Laughlin; Jennifer Payne; Stanton L. Gerson; Hillard M. Lazarus

Book ID: 116277920
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 276 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, etoposide, cytarabine, and d

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas

✍ P. Schütt; J. Passon; P. Ebeling; A. Welt; S. Müller; K. Metz; T. Moritz; S. See 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Double High Dose Salvage Therapy With Do

Double High Dose Salvage Therapy With Dose-Intensified Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Re-Induction Followed by High-Dose Melphalan (HDM) and Autologous Stem Cell Transplantation (ASCT) Consolidation for Relapsed/Refractory Hodgkin Lymphoma

✍ M. Shafey; Q. Duan; J.A. Russell; P. Duggan; A. Balogh; D.A. Stewart 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Feasibility and Efficacy of High-Dose Me

Feasibility and Efficacy of High-Dose Melphalan, Cyclophosphamide, Etoposide, and Dexamethasone (LEED) Chemotherapy with or without Rituximab Followed by Autologous Stem Cell Transplantation for Aggressive and Relapsed Non-Hodgkin’s Lymphoma

✍ Li-na Han; Jin Zhou; Takayuki Hirose; Yosuke Imai; Takuro Ishiguro; Takaaki Chou 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 137 KB